| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.013 | 0.9 |